• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Sam Elgawly, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Jeffrey Gibbs, MD

Latest:

Corticosteroid Premedication for Infliximab Remains Unnecessarily Common

Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from corticosteroids.


Mohammad Jafari, HBSc

Latest:

The Persistent Pandemic of Violence Against Health Care Workers

The problem of violence against health care workers has escalated across the world, and tackling this issue requires the support of administrators.


Sajana K. Patel, MPH

Latest:

Transitional Care Management Visits to Improve Coordination of Care

Inspira Care Connect, LLC, an accountable care organization, incorporated transitional care management services into its postdischarge follow-up process to prevent avoidable utilization of health care services and costs.


Jason Bergsbaken, PharmD, MBA, BCOP

Latest:

A Pharmacist’s Perspective on Optimizing Therapy Selection and Deprescribing in Oncology: Jason Bergsbaken, PharmD, MBA, BCOP

Jason Bergsbaken, PharmD, MBA, BCOP, explains the value of pharmacist involvement in precision molecular tumor boards and end-of-life care discussions, highlighting their role in ensuring evidence-based therapy selection, patient-specific recommendations, and shared decision-making that aligns treatment with individual goals.


Gunnar Esiason

Latest:

Contributor: It’s Time to Talk About Paying Clinical Trial Participants More

There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.


Anita H. Yuan, PhD, MPH

Latest:

Patients’ Needs Following Emergency Care for Ambulatory Care–Sensitive Conditions

To inform intervention development, we assessed for medication changes and patient care needs following treat-and-release Veterans Affairs emergency department visits for chronic ambulatory care–sensitive conditions.


Carmen A. Carrillo, MA, MHS

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Rahul Rastogi, MD

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


Bruce L. Jacobs, MD, MPH

Latest:

Comparison of Primary Payer in Cancer Registry and Discharge Data

Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.


Lionel Chow, MD, PhD

Latest:

Exploring The Future of NF1-PN Management

Panelists discuss the future of NF1-associated plexiform neurofibromas management, highlighting the potential for advances in targeted therapies, gene therapies, and personalized medicine to offer more effective, tailored treatments, while emphasizing early detection, improved imaging, and a greater focus on quality of life through psychosocial support, pain management, and functional rehabilitation.


Lewei (Allison) Lin, MD

Latest:

Impact of COVID-19 on Specialty Televisits in a Large Integrated Health Care System

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.


Joseph Carrington, DO

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Laurie Slovarp, PhD, CCC-SLP

Latest:

Provider Shortages, Coverage, Cost Are Top Barriers to Care: CHEST 2025 Experts

Experts at CHEST 2025 highlight rising costs, insurance complexity, and workforce shortages as major barriers to health care access in the US.


Dr Davey Daniel | Image Credit: OneOncology
Davey Daniel, MD

Latest:

Tackling AI Bias, Expanding Its Role in Precision Oncology: Davey Daniel, MD

Davey Daniel, MD, shares strategies to prevent bias in artificial intelligence (AI) and outlining future opportunities for its adoption in precision oncology.


Glenn Wirick
Glenn Wirick

Latest:

Contributor: How to Become a Star Ratings “Triple Threat” With CAHPS, Medication Adherence, and an SDOH-First Approach to Member Engagement

Medicare Advantage plans can implement 3 simple steps to make sure that they are competitive in the modern Stars environment.


Shealeigh A. Inselman, BS

Latest:

Impact of Medical Care Coordination Intervention on Patient Activation

This observational evaluation compared an adult medical care coordination intervention with usual care and found that the intervention was associated with significant improvements in patient activation.



Jennifer Bautista, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Hui-Jie Lee, PhD

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Oliver Díaz Espinosa, PhD

Latest:

Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.


Kathryn Colborn, PhD, MSPH

Latest:

Modeling of an Alternative Reimbursement Method for Palliative Care

The authors modeled a version of the Patient and Caregiver Support for Serious Illness alternative reimbursement structure for palliative care using data from the Statin Trial.


William Hart-Davidson, PhD

Latest:

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.


Jill M. Killian, BS

Latest:

Patient-Centered Communication and Outcomes in Heart Failure

Among community patients living with heart failure, excellent and good patient-centered communication was associated with a reduced risk of death.


Harmit Patel, MS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Joshua K. Sabari, MD

Latest:

Subcutaneous Treatments Can Save Chair Time, Decrease Infusion Reaction in NSCLC: Joshua K. Sabari, MD

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment.


John Urwin, MD

Latest:

Organizational Capacity Among Hospitals in Medicare and Commercial Bundled Payments

A national survey demonstrated differences in organizational capacity between hospitals participating in Medicare bundled payment programs and those coparticipating in both Medicare and commercial bundled payment programs.


Brenda M. McGrath, PhD

Latest:

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits

This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.


Danielle Haney, PhD

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.


Maruf Haider, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.